Key result
Treatment of early cases of poliomyelitis with normal serum of proved protective power showed no advantage over treatment with convalescent serum.
Why the study?
Does normal serum of proved protective power provide an advantage over convalescent serum in early cases of poliomyelitis?
Does normal serum of proved protective power provide an advantage over convalescent serum in early cases of poliomyelitis?
Normal serum with protective power showed no clinical advantage over convalescent serum in treating early cases of poliomyelitis.
No takes yet. Share an insight, caveat, or question.
Normal serum offers no advantage over convalescent serum in early poliomyelitis; leaves open questions on serum efficacy pending randomized data.
Maurice Brodie (1932) studied Poliomyelitis. Normal serum of proved protective power vs. Convalescent serum was evaluated on Clinical advantage (undefined). Treatment of early cases of poliomyelitis with normal serum of proved protective power showed no advantage over treatment with convalescent serum.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: